Fenebrutinib
Fenebrutinib an orally administered, small molecule, agammaglobulinaemia tyrosine kinase inhibitor, is being developed by Genentech for the treatment of autoimmune disorders. Reference standards of Fenebrutinib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Fenebrutinib - API Standards
[catalogue_number] => PA 06 1510000
[category_ids] => ,81,123,78,75,76,82,
[chemical_name] =>
[weight] => 664.81
[form] => C37H44N8O4
[cas] => 1434048-34-6
[pslug] => 1434048-34-6-fenebrutinib-pa061510000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Fenebrutinib - API Standards
Catalogue No.:PA 06 1510000
Molecular Formula : C37H44N8O4
Molecular Weight : 664.81